Detalhe da pesquisa
1.
Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma.
BMJ Case Rep
; 20142014 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-24872478